Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold
Paptawan Suwanhom, Jirakrit Saetang, Pasarat Khongkow, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4895-4895
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 75
A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease
Stergiani-Chrysovalanti Peitzika, Eleni Pontiki
Molecules (2023) Vol. 28, Iss. 3, pp. 1084-1084
Open Access | Times Cited: 55
Green synthesis, biological and molecular docking of some novel sulfonamide thiadiazole derivatives as potential insecticidal against Spodoptera littoralis
Ahmed M. M. El‐Saghier, Souhaila S. Enaili, Asmaa M. Kadry, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 49
Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α‐glucosidase, α‐amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation
Ahmed Ragab, Mohamed A. Salem, Yousry A. Ammar, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 8
TeMac™ ameliorates memory impairment and cholinergic dysfunction in rats induced by scopolamine
Bruno Dupon Ambamba Akamba, Fils Armand Ella, Dany Joël Ngassa Ngoumen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors
Shehryar Hameed, Khalid Mohammed Khan, Parham Taslimi, et al.
International Journal of Biological Macromolecules (2022) Vol. 211, pp. 653-668
Closed Access | Times Cited: 29
Synthesis and evaluation of coumarin derivatives on antioxidative, tyrosinase inhibitory activities, melanogenesis, and in silico investigations
Kasemsiri Chandarajoti, Jiraporn Kara, Paptawan Suwanhom, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities
Shehryar Hameed, Khalid Mohammed Khan, Uzma Salar, et al.
International Journal of Biological Macromolecules (2022) Vol. 221, pp. 1294-1312
Closed Access | Times Cited: 24
Sustainable approaches towards the synthesis of quinoxalines: An update
Asim Kumar, Tejas M. Dhameliya, Kirti Rani, et al.
Journal of Molecular Structure (2022) Vol. 1259, pp. 132732-132732
Closed Access | Times Cited: 19
Anti-acetylcholinesterase mechanism of kaempferol and its synergistic effect with galanthamine hydrobromide
Wenli Shi, Guowen Zhang, Yijing Liao, et al.
Food Bioscience (2023) Vol. 56, pp. 103174-103174
Closed Access | Times Cited: 8
Development of new donepezil analogs: synthesis, biological screening and in silico study rational
Zeinab Mahmoud, Hadeer S. Sayed, Lamia W. Mohamed, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 10, pp. 1754-1770
Open Access | Times Cited: 13
Novel Lawsone–Quinoxaline Hybrids as New Dual Binding Site Acetylcholinesterase Inhibitors
Paptawan Suwanhom, Teerapat Nualnoi, Pasarat Khongkow, et al.
ACS Omega (2023)
Open Access | Times Cited: 7
Chemistry, Synthesis, and Structure Activity Relationship of Anticancer Quinoxalines
Mohamed F. Zayed
Chemistry (2023) Vol. 5, Iss. 4, pp. 2566-2587
Open Access | Times Cited: 6
Drug Candidates for the Treatment of Alzheimer’s Disease: New Findings from 2021 and 2022
Sujatha L. Motebennur, B. P. Nandeshwarappa, Manjunatha S. Katagi
Drugs and Drug Candidates (2023) Vol. 2, Iss. 3, pp. 571-590
Open Access | Times Cited: 5
Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors
Aiten M. Soliman, Walid M. Ghorab, Dina M. Lotfy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Chlorine‐Thymol Substituted Silicon (IV) Phthalocyanines: Synthesis, Characterization, and In Vitro Acetylcholinesterase (AChE)/Butyrylcholinesterase (BChE) Inhibitory Effect
Ayşe Aktaş Kamiloğlu, Tayfun Arslan, Aşkın TEKİN, et al.
Applied Organometallic Chemistry (2024) Vol. 39, Iss. 1
Closed Access | Times Cited: 1
An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020–2024)
Aly M. Waseem, Ranya Mohammed Elmagzoub, Mervat Mohammed Mazhar Abdelgadir, et al.
Results in Chemistry (2024), pp. 101989-101989
Open Access | Times Cited: 1
Phenolic glycosides and bioactive Mangifera indica L. kernel extract as neuroprotective agents against LPS-induced Alzheimer's disease in rats
Alia Y. Ragheb, Mohamed A. El-Ansari, Ola A. Heikal, et al.
South African Journal of Botany (2023) Vol. 157, pp. 37-43
Closed Access | Times Cited: 4
Computational model for lipid binding regions in phospholipase (Ves a 1) from Vespa venom
Nawanwat C. Pattaranggoon, Sakda Daduang, Thanyada Rungrotmongkol, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Computational study of 2-aryl quinoxaline derivatives as α-amylase inhibitors
Lhoucine Naanaai, Abdellah El Aissouq, Hicham Zaitan, et al.
Chemical Data Collections (2023) Vol. 47, pp. 101079-101079
Closed Access | Times Cited: 3
Facile synthesis of quinoxaline catalyzed by iron-based carbon material in water
Fuying Zhu, Yamei Lin
Tetrahedron (2023) Vol. 150, pp. 133752-133752
Closed Access | Times Cited: 2
Novel quinolone-grafted chitosan derivatives with potential therapeutic properties: synthesis, characterization, in silico investigations, cholinesterase inhibitory potential, and antioxidant activity
Arif Mermer, Yakup Şirin, Houssem Boulebd
Polymer Bulletin (2024) Vol. 81, Iss. 15, pp. 14031-14048
Open Access
Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes
Berkant Kurban, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Polycyclic aromatic compounds (2024), pp. 1-21
Closed Access
Identification of promising cancer target proteins of major sesquiterpene lactones from Vernonia spp
Muhammad Faisal, Potchanapond Graidist, Varomyalin Tipmanee
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access
In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase
Błażej Grodner, Mariola Napiórkowska, Dariusz Maciej Pisklak
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 270-270
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top